Company / Revenue per Share
PUMA BIOTECHNOLOGY, INC. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.80
FY2025
5-year range
$4.79 / $6.79
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share returned to growth in FY2025 after 3 years of decline, reaching $4.80.
Based on SEC 10-K filings.
4.80 in FY2025 with a 5-year CAGR of -5.6%.
Declined from $5.46 to $4.80 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- -5.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 0.3% year-over-year.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2018.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.80 | +0.3% |
| FY2024 | $4.79 | -12.4% |
| FY2023 | $5.46 | -0.1% |
| FY2022 | $5.47 | -19.5% |
| FY2021 | $6.79 | +6.1% |
| FY2020 | $6.40 | +786.3% |
| FY2019 | $0.72 | +346.9% |
| FY2018 | $0.16 | -78.5% |
| FY2017 | $0.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026